Literature DB >> 8964033

Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

E Bergogne-Bérézin1, K J Towner.   

Abstract

Mesh：

Substances：

Year:  1996        PMID： 8964033      PMCID： PMC172888          DOI： 10.1128/CMR.9.2.148

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN： 0893-8512            Impact factor:   26.132


× No keyword cloud information.
  182 in total

1.  Outbreak of a multiply resistant Acinetobacter in a surgical intensive care unit: epidemiology and control.

Authors:  M Castle; J H Tenney; M P Weinstein; T C Eickhoff
Journal:  Heart Lung       Date:  1978 Jul-Aug       Impact factor: 2.210

2.  Characterisation of a siderophore from Acinetobacter calcoaceticus.

Authors:  A W Smith; S Freeman; W G Minett; P A Lambert
Journal:  FEMS Microbiol Lett       Date:  1990-06-15       Impact factor: 2.742

3.  Acinetobacter calcoaceticus biovar anitratus septicaemia in a neonatal intensive care unit: epidemiology and control.

Authors:  H Sakata; K Fujita; S Maruyama; H Kakehashi; Y Mori; H Yoshioka
Journal:  J Hosp Infect       Date:  1989-07       Impact factor: 3.926

4.  Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern.

Authors:  H F Retailliau; A W Hightower; R E Dixon; J R Allen
Journal:  J Infect Dis       Date:  1979-03       Impact factor: 5.226

Review 5.  Classification of beta-lactamases.

Authors:  A Bauernfeind
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

6.  A note on the preparation and use of a selective differential medium for the isolation of Acinetobacter spp. from clinical sources.

Authors:  J Holton
Journal:  J Appl Bacteriol       Date:  1983-02

7.  Species, biotype, and bacteriophage type determinations compared with cell envelope protein profiles for typing Acinetobacter strains.

Authors:  P J Bouvet; S Jeanjean; J F Vieu; L Dijkshoorn
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

8.  Nucleic acid homologies among oxidase-negative Moraxella species.

Authors:  J L Johnson; R S Anderson; E J Ordal
Journal:  J Bacteriol       Date:  1970-02       Impact factor: 3.490

9.  Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains.

Authors:  J Vila; M Almela; M T Jimenez de Anta
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

10.  [Nosocomial infections caused by Acinetobacter. Epidemiology and therapeutic difficulties].

Authors:  C Muller-Serieys; J B Lesquoy; E Perez; A Fichelle; B Boujeois; M L Joly-Guillou; E Bergogne-Berezin
Journal:  Presse Med       Date:  1989-01-28       Impact factor: 1.228
View more
  447 in total

1.  Skin carriage of acinetobacters in Hong Kong.

Authors:  Y W Chu; C M Leung; E T Houang; K C Ng; C B Leung; H Y Leung; A F Cheng
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Sequence analysis of ARI-1, a novel OXA beta-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92.

Authors:  H M Donald; W Scaife; S G Amyes; H K Young
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

3.  Antibody response to lipopolysaccharide in patients colonized or infected with an endemic strain of Acinetobacter genomic species 13 sensu Tjernberg and Ursing.

Authors:  R Pantophlet; H Seifert; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

4.  Effect of desiccation on the ultrastructural appearances of Acinetobacter baumannii and Acinetobacter lwoffii.

Authors:  E T Houang; R T Sormunen; L Lai; C Y Chan; A S Leong
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

5.  Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

6.  Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.

Authors:  F Lopez-Otsoa; L Gallego; K J Towner; L Tysall; N Woodford; D M Livermore
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides.

Authors:  R Pantophlet; L Brade; H Brade
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

8.  Detection of carbapenemase-producing Acinetobacter baumannii in a hospital.

Authors:  A Takahashi; S Yomoda; I Kobayashi; T Okubo; M Tsunoda; S Iyobe
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

9.  Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitals.

Authors:  A Ribera; J Vila; F Fernández-Cuenca; L Martínez-Martínez; A Pascual; A Beceiro; G Bou; J M Cisneros; J Pachón; J Rodríguez-Baño
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

10.  Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway.

Authors:  Timothy R Sampson; Xiang Liu; Max R Schroeder; Colleen S Kraft; Eileen M Burd; David S Weiss
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.